Page last updated: 2024-08-22

ruthenium and B-Cell Lymphoma

ruthenium has been researched along with B-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dos Santos, WB; Goulart, LR; Hamaguchi, A; Homsi-Brandenburgo, MI; Nomizo, A; Pavanin, LA; Silveira-Lacerda, Ede P; Soares, AM; Vilanova-Costa, CA	1

Other Studies

1 other study(ies) available for ruthenium and B-Cell Lymphoma

Article	Year
The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents selective cytotoxicity against murine B cell lymphoma (A-20), murine ascitic sarcoma 180 (S-180), human breast adenocarcinoma (SK-BR-3), and human T cell leukemia (Jurkat) tum Biological trace element research, 2010, Volume: 135, Issue:1-3 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytotoxicity, Immunologic; Female; Humans; Jurkat Cells; Lymphoma, B-Cell; Mice; Ruthenium; Ruthenium Compounds; Sarcoma 180	2010

Article

Year

The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents selective cytotoxicity against murine B cell lymphoma (A-20), murine ascitic sarcoma 180 (S-180), human breast adenocarcinoma (SK-BR-3), and human T cell leukemia (Jurkat) tum

Biological trace element research, 2010, Volume: 135, Issue:1-3

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytotoxicity, Immunologic; Female; Humans; Jurkat Cells; Lymphoma, B-Cell; Mice; Ruthenium; Ruthenium Compounds; Sarcoma 180

2010